Testing to rule in or rule out Alzheimer’s is desperately needed to differentiate Alzheimer’s Disease from other forms of dementia. Access to testing like what’s being developed now will be a game changer in research. The ability to detect tau proteins in the blood years before dementia symptoms start will inspire patients to take the steps necessary, starting with the Bredesen protocol, to prevent AD from ever affecting them! We are watching the research like a hawk.
Feel free to contact us if you have questions about testing, risk factors, or lifestyle interventions you can start now.
Read the article at the New York Times here: https://rcl.ink/hAF